Skip to main content
. 2022 May 21;14:69. doi: 10.1186/s13195-022-01009-4

Table 1.

AD cohorts available for exploration using ADataViewer

Cohort Consortium Patients at baseline Modalities Longitudinal (yes/no) Study type
A4 [16] Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease 6945 7 Noa Clinical trial
ABVIB [17] Aging Brain: Vasculature, Ischemia, and Behavior 280 2 Yes Observational study
ADNI [18] The Alzheimer’s Disease Neuroimaging Initiative 2249 12 Yes Observational study
AIBL [19] The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing 1378 9 Yes Observational study
ANMerge [20] AddNeuroMed 1703 10 Yes Observational study
ARWIBO [21] Alzheimer’s Disease Repository Without Borders 2617 10 Yes Observational study
DOD-ADNI [22] Effects of TBI & PTSD on Alzheimer’s Disease in Vietnam Vets 458 11 Yes Observational study
EDSD [23] The European DTI Study on Dementia 474 7 No Observational study
EMIF-1000 [24] European Medical Information Framework 1199 10 No Meta-cohort
EPAD V.IMI [25] European Prevention of Alzheimer’s Dementia 2096 9 Yes Observational study
I-ADNI [26]

The Italian Alzheimer’s Disease

Neuroimaging Initiative

262 5 No Observational study
JADNI [27] Japanese Alzheimer’s Disease Neuroimaging Initiative 567 9 Yes Observational study
NACC [28] The National Alzheimer’s Coordinating Center 40,948 11 Yes Memory clinic database
OASIS-1 [29] and OASIS-2 [30] Open Access Series of Imaging Studies 564 3 Yes Observational study
PREVENT-AD [31] Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease 348 8 Yes Clinical trial
PharmaCog [32] Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development 147 6 Yes Observational study
ROSMAP [33] The Religious Orders Study and Memory and Aging Project 3626 7 Yes Observational study
VASCULAR [34] The Vascular Contributors to Prodromal Alzheimer’s disease 250 8 No Non-interventional cohort study
VITA [35] Vienna Transdanube Aging 606 5 Yes Observational study
WMH-AD [36] White Matter Hyperintensities in Alzheimer’s Disease 90 5 No Observational study

A complete overview about the collected data modalities can be found under https://adata.scai.fraunhofer.de/modality

aFollow-up assessments were planned for A4 but no according data was released at the time of this publication